Market capitalization | $179.05m |
Enterprise Value | $166.50m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 21.76 |
EV/Sales (TTM) EV/Sales | 1.38 |
P/S ratio (TTM) P/S ratio | 1.48 |
P/B ratio (TTM) P/B ratio | 8.74 |
Revenue growth (TTM) Revenue growth | 5.14% |
Revenue (TTM) Revenue | $120.80m |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
5 Analysts have issued a Joint Corp forecast:
5 Analysts have issued a Joint Corp forecast:
Sep '24 |
+/-
%
|
||
Revenue | 121 121 |
5%
5%
|
|
Gross Profit | 104 104 |
9%
9%
|
|
EBITDA | 7.71 7.71 |
27%
27%
|
EBIT (Operating Income) EBIT | 1.86 1.86 |
41%
41%
|
Net Profit | -17 -17 |
1,016%
1,016%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
The Joint Corp. (United States) engages in the development, ownership, operation, support and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment comprises of the operating activities of the company owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.
Head office | United States |
CEO | Sanjiv Razdan |
Employees | 794 |
Founded | 2010 |
Website | www.thejoint.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.